Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
BMC Palliative Care|January 5, 2023
Increasing palliative care capacity in primary care: study protocol of a cluster randomized controlled trial of the CAPACITI training programHsien Seow, Daryl Bainbridge, Samantha Winemaker, et al.
Transplantation and Cellular Therapy|November 15, 2024
Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDSMichael Radford, Alejandro Garcia-Horton, Rohail Badami, et al.
Journal of Bone Oncology|March 8, 2021
Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalationSharon McGee, Mashari AlZahrani, Carol Stober, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort StudyArif Ali Awan, Deanna Saunders, Gregory Pond, et al.
Current Oncology (Toronto, Ont.)|June 2, 2021
Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate CancerMegan M Tu, Mark Clemons, Carol Stober, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2022
Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trialPaola Muti, Andrea Sacconi, Claudio Pulito, et al.
International Journal of Radiation Oncology, Biology, Physics|January 7, 2023
BRACHY: A Randomized Trial to Evaluate Symptom Improvement in Advanced Non-Small Cell Lung Cancer Treated With External Beam Radiation With or Without High-Dose-Rate Intraluminal BrachytherapyRanjan Sur, Gregory Pond, Conrad Falkson, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer CareAna-Alicia Beltran-Bless, Mark Clemons, Lisa Vandermeer, et al.
Haematologica|February 5, 2026
Second primary malignancy in multiple myeloma: does a prior malignancy matter?Alissa Visram, Hsien Seow, Rajeshkar Chakraborty, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 23, 2021
Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient surveyMashari Alzahrani, Mark Clemons, Marta Sienkiewicz, et al.
Pageof 9